- Home
- MHK vs LNTH Comparison
MHK vs LNTH Comparison
Compare MHK & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHK
- LNTH
- Stock Information
- Founded
- MHK 1988
- LNTH 1956
- Country
- MHK United States
- LNTH United States
- Employees
- MHK N/A
- LNTH N/A
- Industry
- MHK Home Furnishings
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MHK Consumer Discretionary
- LNTH Health Care
- Exchange
- MHK Nasdaq
- LNTH Nasdaq
- Market Cap
- MHK 7.2B
- LNTH 7.5B
- IPO Year
- MHK 1992
- LNTH 2015
- Fundamental
- Price
- MHK $101.16
- LNTH $73.86
- Analyst Decision
- MHK Buy
- LNTH Strong Buy
- Analyst Count
- MHK 14
- LNTH 5
- Target Price
- MHK $141.64
- LNTH $133.80
- AVG Volume (30 Days)
- MHK 767.8K
- LNTH 1.5M
- Earning Date
- MHK 05-01-2025
- LNTH 05-07-2025
- Dividend Yield
- MHK N/A
- LNTH N/A
- EPS Growth
- MHK N/A
- LNTH N/A
- EPS
- MHK 7.66
- LNTH 3.53
- Revenue
- MHK $10,683,300,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- MHK N/A
- LNTH $4.63
- Revenue Next Year
- MHK $3.03
- LNTH $9.35
- P/E Ratio
- MHK $13.22
- LNTH $20.92
- Revenue Growth
- MHK N/A
- LNTH 12.53
- 52 Week Low
- MHK $96.24
- LNTH $73.11
- 52 Week High
- MHK $164.29
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- MHK 39.43
- LNTH 26.09
- Support Level
- MHK $105.98
- LNTH $73.11
- Resistance Level
- MHK $108.00
- LNTH $81.50
- Average True Range (ATR)
- MHK 2.42
- LNTH 3.44
- MACD
- MHK -0.36
- LNTH -1.23
- Stochastic Oscillator
- MHK 8.71
- LNTH 2.10
About MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.